Clinical trial
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH)…
NCT00474045 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00474045 |
|---|---|
| Title | Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes |
| Official title | A Randomised, Parallel-group, Open-labelled, Multinational Trial Comparing the Efficacy and Safety of Insulin Detemir (Levemir®) Versus Human Insulin (NPH Insulin), Used in Combination With Insulin Aspart as Bolus Insulin, in the Treatment of Pregnant Women With Type 1 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir, NPH insulin, insulin aspart |
| Enrollment | 470 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | May 16, 2007 |
| Last update posted | Mar 10, 2017 |
| Countries | Argentina, Australia, Austria, Brazil, Canada, Croatia, Denmark, Finland, France, Ireland, Israel, Norway and 5 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: